Scalable, xeno-free expansion of mesenchymal stem cells in a fixed-bed bioreactor

Successful expansion of mesenchymal stem cells (MSCs) using Rooster Bio’s xeno-free MSC platform in Univercells Technologies’ scale-X™ fixed-bed bioreactor

The collaboration highlights seamless process transfer, rapid cell attachment, optimized harvesting with high viability (>96%), and offering, seamless linear scalability.  Key innovations include predictive bioprocess monitoring with the Skaia™ vision application software and cost-effective solutions for advanced therapy manufacturing.

Learning points

  • Seamless process transfer
  • Rapid cell attachment & optimized harvesting (>96% viability)
  • Predictive bioprocess monitoring with the Skaia™ vision application software
  • Cost-effective solutions for advanced therapy manufacturing

Watch the webinar on-demand

Subscribe to
our newsletter